Finance

Lists
Why is MRKR up 3,35%?
Dive Deeper
MRKR:NASDAQ
Marker Therapeutics Inc
0,92 $
+3,35%
(+0,030) 1D
0,98 $
+6,41% (+0,059)
After hours
Closed: 15 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
0,96 $
High
0,96 $
Low
0,88 $
Mkt. cap
15,42 млн
Avg. vol.
78,61 мың
Volume
120,79 м.
52-wk high
2,46 $
52-wk low
0,84 $
EPS
-0,47 $
Beta
1,53
Shares outstanding
16,67 млн
No. of employees
5
Open
0,96 $
High
0,96 $
Low
0,88 $
Mkt. cap
15,42 млн
Avg. vol.
78,61 мың
Volume
120,79 м.
52-wk high
2,46 $
52-wk low
0,84 $
EPS
-0,47 $
Beta
1,53
Shares outstanding
16,67 млн
No. of employees
5
News stories
From web sources and news partners
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersХьюстон, Техас, Америка Құрама Штаттары
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current 0,92 $
10,00 $ (+986,96%)
Average
9,00 $ (+878,26%)
Lowest
8,00 $ (+769,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
10,00 $
+987%
09/21/2026
John Newman
Canaccord Genuity
Buy
Maintained
8,00 $
+769,6%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,23 млн
1,10 млн
751,69 м.
681,58 м.
Cost of goods sold
2,35 млн
2,14 млн
2,84 млн
1,48 млн
Cost of revenue
2,35 млн
2,14 млн
2,84 млн
1,48 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,02 млн
846,61 м.
1,23 млн
1,14 млн
Operating expense
1,02 млн
846,61 м.
1,23 млн
1,14 млн
Total operating expenses
3,37 млн
2,99 млн
4,07 млн
2,62 млн
Operating income
-2,14 млн
-1,88 млн
-4,07 млн
-2,62 млн
Other non operating income
-
-
760,37 м.
681,58 м.
EBT including unusual items
-2,00 млн
-1,72 млн
-3,18 млн
-1,83 млн
EBT excluding unusual items
-2,00 млн
-1,72 млн
-3,18 млн
-1,83 млн
Income tax expense
-
-15,16 мың
-
-
Effective tax rate
-
0,88%
-
-
Other operating expenses
-
-
-
-
Net income
-2,00 млн
-1,70 млн
-3,18 млн
-1,83 млн
Net profit margin
-162,11%
-154,35%
-
-
Earnings per share
-0,12
-0,04
-0,16
-0,09
Interest and investment income
138,06 м.
165,63 м.
132,89 м.
112,56 м.
Interest expense
-
-
-
-
Net interest expenses
138,06 м.
165,63 м.
132,89 м.
112,56 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары